Heart Failure Reviews

Papers
(The median citation count of Heart Failure Reviews is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Heart failure and COVID-19140
Biomarkers for the diagnosis and management of heart failure133
COVID-19 and myocarditis: a systematic review and overview of current challenges116
Machine learning versus conventional clinical methods in guiding management of heart failure patients—a systematic review54
Anthracycline-induced cardiotoxicity: mechanisms of action, incidence, risk factors, prevention, and treatment53
Mechanisms of COVID-19-induced heart failure: a short review44
Extracellular matrix–based biomaterials for cardiac regeneration and repair44
SGLT2-inhibitors; more than just glycosuria and diuresis42
Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments42
Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers41
Polypharmacy definition and prevalence in heart failure: a systematic review41
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets41
Clinical inertia in the treatment of heart failure: a major issue to tackle40
Anthracycline-induced cardiotoxicity and renin-angiotensin-aldosterone system—from molecular mechanisms to therapeutic applications38
The transverse aortic constriction heart failure animal model: a systematic review and meta-analysis34
The Elabela-APJ axis: a promising therapeutic target for heart failure33
Therapeutic angiogenesis with exosomal microRNAs: an effectual approach for the treatment of myocardial ischemia33
The role and molecular mechanism of epigenetics in cardiac hypertrophy31
The role of non-invasive devices for the telemonitoring of heart failure patients29
Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness27
Mitochondrial abnormalities: a hub in metabolic syndrome-related cardiac dysfunction caused by oxidative stress26
Detection of myocardial fibrosis by speckle-tracking echocardiography: from prediction to clinical applications26
Resistance training in heart failure patients: a systematic review and meta-analysis26
Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges25
A meta-analysis of microRNA expression profiling studies in heart failure25
Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials23
Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors23
Immunity and inflammation: the neglected key players in congenital heart disease?22
Mechanisms underlying the pathophysiology of heart failure with preserved ejection fraction: the tip of the iceberg22
Multiple roles of cardiac macrophages in heart homeostasis and failure22
Cardiogenic shock and acute kidney injury: the rule rather than the exception22
The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced eject22
Current and emerging drug targets in heart failure treatment21
Ventricular non-compaction review21
The non-invasive assessment of myocardial work by pressure-strain analysis: clinical applications21
Myocarditis following COVID-19 vaccination in adolescents and adults: a cumulative experience of 202121
Cardiorenal syndrome: long road between kidney and heart20
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases20
Effect of beta-blockers on heart failure severity in patients with heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials20
Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide19
Left ventricular hypertrophy and sudden cardiac death19
The roles of epicardial adipose tissue in heart failure19
Angiotensin-converting enzyme 2: a double-edged sword in COVID-19 patients with an increased risk of heart failure19
Effect of exercise on epicardial adipose tissue in adults: a systematic review and meta-analyses19
Filamin C in cardiomyopathy: from physiological roles to DNA variants18
Palliative care needs-assessment and measurement tools used in patients with heart failure: a systematic mixed-studies review with narrative synthesis18
SGLT2 inhibitors: a focus on cardiac benefits and potential mechanisms18
SGLT2 inhibitors break the vicious circle between heart failure and insulin resistance: targeting energy metabolism18
Sodium glucose cotransporter 2 inhibitors: mechanisms of action in heart failure18
Heart failure and atrial fibrillation: new concepts in pathophysiology, management, and future directions18
Management of RAASi-associated hyperkalemia in patients with cardiovascular disease17
Heart–lung interactions in COVID-19: prognostic impact and usefulness of bedside echocardiography for monitoring of the right ventricle involvement17
Pirfenidone as a novel cardiac protective treatment17
Prognostic value of natriuretic peptides in heart failure: systematic review and meta-analysis17
Machine learning and statistical methods for predicting mortality in heart failure16
Device-based treatment options for heart failure with preserved ejection fraction16
Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis16
The protective effects of 17-β estradiol and SIRT1 against cardiac hypertrophy: a review16
SGLT2 inhibitors and cardiovascular and renal outcomes: a meta-analysis and trial sequential analysis16
The use of diflunisal for transthyretin cardiac amyloidosis: a review16
Hospitalisation costs associated with heart failure with preserved ejection fraction (HFpEF): a systematic review15
Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure15
Cardiac xenotransplantation: a promising way to treat advanced heart failure15
Lung ultrasound–guided management to reduce hospitalization in chronic heart failure: a systematic review and meta-analysis15
Cardiac complications in inherited mitochondrial diseases15
Creatine deficiency and heart failure15
Right ventricular phenotype, function, and failure: a journey from evolution to clinics14
Transplant and mechanical circulatory support in patients with adult congenital heart disease14
The role of cardiac magnetic resonance imaging in the detection and monitoring of cardiotoxicity in patients with breast cancer after treatment: a comprehensive review14
Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials14
Balloon pulmonary angioplasty vs. pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis14
Effects of catheter-based renal denervation on heart failure with reduced ejection fraction: a meta-analysis of randomized controlled trials14
Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction14
Peripartum cardiomyopathy: a review13
Efficacy of motivational interviewing on enhancing self-care behaviors among patients with chronic heart failure: a systematic review and meta-analysis of randomized controlled trials13
New antidiabetic therapy and HFpEF: light at the end of tunnel?13
Crosstalk between GSK-3β-actuated molecular cascades and myocardial physiology12
The management of atrial fibrillation in heart failure: an expert panel consensus12
Prognostic significance of T1 mapping parameters in heart failure with preserved ejection fraction: a systematic review12
Association of loop diuretics use and dose with outcomes in outpatients with heart failure: a systematic review and meta-analysis of observational studies involving 96,959 patients12
Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction12
Cardiac imaging in cardiotoxicity: a focus on clinical practice12
Epidemiology and clinical manifestations of cardiac amyloidosis12
Effects of bromocriptine in peripartum cardiomyopathy: a systematic review and meta-analysis12
Left atrial structure and function in heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF): systematic review and meta-analysis12
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction11
Dilated cardiomyopathy: a new insight into the rare but common cause of heart failure11
Cost-effectiveness analyses of sacubitril-valsartan for heart failure11
Definition of left ventricular remodelling following ST-elevation myocardial infarction: a systematic review of cardiac magnetic resonance studies in the past decade11
Ultrafiltration is better than diuretic therapy for volume-overloaded acute heart failure patients: a meta-analysis11
The heart and gut relationship: a systematic review of the evaluation of the microbiome and trimethylamine-N-oxide (TMAO) in heart failure11
Hormonal prostate cancer therapies and cardiovascular disease: a systematic review11
Beneficial effects on kidney during treatment with sodium-glucose cotransporter 2 inhibitors: proposed role of ketone utilization11
Cor pulmonale: the role of traditional and advanced echocardiography in the acute and chronic settings10
Comparative effects of furosemide and other diuretics in the treatment of heart failure: a systematic review and combined meta-analysis of randomized controlled trials10
Targeting mitochondrial dysfunction with elamipretide10
Cardiotoxicity in HER2-positive breast cancer patients10
Cardiac contractility modulation for the treatment of heart failure with reduced ejection fraction10
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis10
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction9
Cardiac contractility modulation for patient with refractory heart failure: an updated evidence-based review9
Vitamin C: historical perspectives and heart failure9
The genetics of cardiac amyloidosis9
Fibrosis in hypertrophic cardiomyopathy: role of novel echo techniques and multi-modality imaging assessment9
Diagnostic algorithm for HFpEF: how much is the recent consensus applicable in clinical practice?9
Diabetes-related cardiovascular and economic burden in patients hospitalized for heart failure in the US: a recent temporal trend analysis from the National Inpatient Sample9
Targeting the forkhead box protein P1 pathway as a novel therapeutic approach for cardiovascular diseases9
A critical approach for successful use of circulating microRNAs as biomarkers in cardiovascular diseases: the case of hypertrophic cardiomyopathy9
A systematic review exploring the significance of measuring epicardial fat thickness in correlation to B-type natriuretic peptide levels as prognostic and diagnostic markers in patients with or at ris9
Cognitive impairment in heart failure: clinical implications, tools of assessment, and therapeutic considerations9
MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers9
Serum potassium and heart failure: association, causation, and clinical implications9
Subclinical cardiac damage in cancer patients before chemotherapy9
The soluble catalytic ectodomain of ACE2 a biomarker of cardiac remodelling: new insights for heart failure and COVID199
Prognostic impact of antiplatelet therapy in Takotsubo syndrome: a systematic review and meta-analysis of the literature8
Speckle tracking echocardiography in primary mitral regurgitation: should we reconsider the time for intervention?8
Weighing in on heart failure: the potential impact of bariatric surgery8
Research progress of biomarkers in early detection of chemotherapy-induced cardiotoxicity8
Vaccines against components of the renin–angiotensin system8
Psychological stress in heart failure: a potentially actionable disease modifier8
Optimal effectiveness of heart failure management — an umbrella review of meta-analyses examining the effectiveness of interventions to reduce (re)hospitalizations in heart failure8
Complications in children with ventricular assist devices: systematic review and meta-analyses8
Soluble ST2: a valuable prognostic marker in heart failure8
Large animal models of heart failure with preserved ejection fraction8
The therapeutic effects of upgrade to cardiac resynchronization therapy in pacing-induced cardiomyopathy or chronic right ventricular pacing patients: a meta-analysis8
Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors8
Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization: disclosing the arrhythmic substrate within the heart muscle8
Paradigm shift in heart failure treatment: are cardiologists ready to use gliflozins?8
Is heart failure with preserved ejection fraction a ‘dementia’ of the heart?8
Cardiac resynchronization therapy in heart failure patients: tough road but clear future8
Etiology and pathophysiology of heart failure in people with HIV8
Left atrial assist device for heart failure with preserved ejection fraction: initial results with torque control mode in diastolic heart failure model8
Impact of atrial fibrillation on the outcomes of transcatheter mitral valve repair using MitraClip: a systematic review and meta-analysis8
Physical activity and exercise training in heart failure with preserved ejection fraction: gathering evidence from clinical and pre-clinical studies8
Beyond genomics—technological advances improving the molecular characterization and precision treatment of heart failure7
The cardiosplenic axis: the prognostic role of the spleen in heart failure7
A systematic review on focal takotsubo syndrome: a not-so-small matter7
ST-elevation myocardial infarction among cardiac amyloidosis patients; a national readmission database study7
Clinical comparison of V122I genotypic variant of transthyretin amyloid cardiomyopathy with wild-type and other hereditary variants: a systematic review7
Assessment of acute heart failure prognosis: the promising role of prognostic models and biomarkers7
Ventricular arrhythmias and ARNI: is it time to reappraise their management in the light of new evidence?7
Speckle tracking echocardiography in heart failure development and progression in patients with apneas7
The role of lymphangiogenesis in cardiovascular diseases and heart transplantation7
Evaluation of donor heart for transplantation7
Global longitudinal strain predicts responders after cardiac resynchronization therapy—a systematic review and meta-analysis7
Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 20207
State-of-the art review: Noncompaction cardiomyopathy in pediatric patients7
Cardiogenic shock in autoimmune rheumatologic diseases: an insight on etiologies, management, and treatment outcomes7
Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy7
Heart failure in the adult Ebstein patient7
Peripartum cardiomyopathy7
Angiotensin receptor-neprilysin inhibition in patients with acute decompensated heart failure: an expert consensus position paper7
Mechanistic implications of altered protein expression in rheumatic heart disease7
Cardiovascular disease associated with methamphetamine use: a review7
0.29483604431152